Compound 7P

Compound 7P is a synthetic small molecule belonging to the arylsulfonamide-acetamide chemical class. In neurochemical and regenerative biology literature, it is primarily studied for its structural capacity to influence complex cellular morphologies.

Because the designation “Compound 7P” is a generic project or series label rather than a unique chemical name, it has occasionally been applied to completely unrelated structures across separate pharmacological studies (such as a distinct pyranone-carbamate cholinesterase inhibitor described in 2024 literature). To maintain absolute experimental validity and ensure matrix reproducibility, this reference material is audited and verified strictly by its definitive registry identifier: CAS 1890208-58-8.

An Important Analytical Distinction: When evaluating this molecule, investigators must anchor their criteria to the specific molecular architecture shown above. This structure consists of a core acetamide bridge linking a 4-methoxypyridin-3-yl group to a heavily substituted p-toluenesulfonamide center bearing an ortho-methoxyphenyl ring. Sourcing material based purely on the text label “7P” introduces substantial experimental risk; every lot supplied by Kimera Chems is explicitly validated against a certified reference standard matching this exact structural fingerprint.

Technical Specifications

Research Applications & Phenotypic Profile

In cellular modeling, Compound 7P is classified as a phenotypic screening hit. Rather than being reverse-engineered to target a pre-selected enzyme or surface receptor, the molecule was identified by observing its macro-effects on living cell assays.

Primary areas of preclinical and in vitro laboratory investigation include:

• Neurite Outgrowth Dynamics: Deployed in primary neuronal cultures to measure and track the enhancement of structural neurite elongation, branching kinetics, and dendritic arborization.

• Axon Regeneration & CNS Injury Modeling: Evaluated within complex structural injury models—including optic nerve injury frameworks—to analyze downstream micro-environmental adaptations during central nervous system regeneration testing.

• Phenotypic Panel Benchmarking: Serving as a structural comparator in high-throughput neuroregeneration screening panels to catalog the functional differences of varying multi-substituted arylsulfonamide frameworks.

Mechanistic Transparency Note: Because Compound 7P was discovered through outward phenotypic responses, its precise upstream molecular target has not yet been definitively mapped. Kimera Chems intentionally details only verified, data-backed literature profiles. Speculative mechanisms occasionally found elsewhere (such as unverified direct thromboxane or primary mitochondrial pathway claims) lack traceable primary source verification and should be treated with appropriate scientific skepticism.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.